(Please note: This is intended to provide an overview, NOT a comprehensive list of diseases treated by BMT/SCT.)
Bone marrow/stem cell transplantation (BMT/SCT) continues to be investigated as a treatment for a number of diseases, and its therapeutic uses are likely to increase. One of its earliest uses was treating leukemia and lymphoma, cancers that affect white blood cells. Today, BMT/SCT is considered by many experts to be standard therapy for these cancers, as well as for neuroblastoma (a type of brain cancer that occurs most frequently in children) and multiple myeloma (a cancer of the bone marrow), and other noncancerous diseases, including anemia and sickle cell disease. BMT/SCT is also being studied for breast, lung and ovarian cancer; germ cell tumors; and numerous other less common cancers in children and adults. In addition, BMT/SCT may be used to effectively treat cancers that have spread from one site to another in the body, cannot be removed surgically, or have failed to respond to other treatments.
Transplantation is also used in a number of noncancerous conditions, including those that affect the blood or immune system. These include severe combined immunodeficiency disease (SCID), sickle-cell disease, various types of anemia, such as aplastic anemia and Fanconi’s anemia, and autoimmune diseases.
Click here to see a longer list of diseases for which bone marrow or stem cell transplants are performed.